Loading
Latest filing published 08 Sept 2021 for Emerald Health Therapeutics, Inc..
No signal scores available.
Jennifer Hepburn appears in our data through filings on Emerald Health Therapeutics, Inc. shares, published by SEDI. Over a trading history stretching from 2 April 2020 to 3 August 2021, the count stands at 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 8 September 2021 came the latest disclosure, an option exercise in Emerald Health Therapeutics, Inc. The median gap between a trade and its publication by SEDI is 36 days. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations